Home / Latest Reports / Preimplantation Genetic Testing Market

Preimplantation Genetic Testing Market By Type And Application - Global Industry Analysis And Forecast To 2023

Published On : June 2022 Pages : 190 Category: Medical Devices Report Code : HC06998

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Preimplantation Genetic Testing Market By Type (Chromosomal Abnormalities, X-linked Diseases, Freeze Embryo Testing, Aneuploidy Screening, HLA Typing, Other PGT Types), Application (Embryo HLA typing for stem cell therapy, IVF Prognosis, Late Onset Genetic Disorders, Inherited Genetic Disease, Other Applications) Forecast 2017 to 2023

Industry Outlook and Trend Analysis

The Preimplantation Genetic Testing Market was worth USD 0.28 Billion in 2017 and is expected to reach approximately USD 0.65 Billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.70% during the forecast period. Preimplantation genetic testing or preimplantation hereditary determination is a method in which the developing lives arranged through in vitro treatment are tried for surrenders before implantation. Preimplantation hereditary testing empowers doctors and to distinguish the deformities exhibit in the incipient organisms and specifically embed sound developing lives in the uterus which builds the odds of conveying a hereditarily solid infant. Preimplantation hereditary testing causes individuals to stay away from the genetic issue that win in the family to be conveyed into the child. The preimplantation procedures include different advances like the gathering of eggs from the mother or egg contributor which is later in vitro treated. Treated eggs are then tried for different hereditary conditions through screening forms. Solid developing lives might be solidified and put away for additionally utilize while unfit foetuses are annihilated. The sound developing lives are embedded to actuate pregnancy. Preimplantation hereditary testing likewise fills another need like sex determination.

Drivers & Restrains

Expanding awareness about preimplantation hereditary testing among individuals experiencing hereditary clutters is relied upon to drive interest for preimplantation hereditary testing techniques as per the Worldwide Qualities Association a non – benefit association pointed towards advancing needs of the uncommon ailments network, there are almost 7000 particular uncommon infections and hereditary or uncommon maladies influence about 350 million individuals all inclusive. Also as indicated by the National Foundations of Wellbeing (NIH), around half individuals influenced by uncommon infections are kids. Developing number of individuals experiencing hereditary maladies are relied upon to build interest for preimplantation hereditary testing systems keeping in mind the end goal to have a sound child. Inferable from high pregnancy chances with preimplantation hereditary testing system when contrasted with other ripeness medications the interest for PGI testing is relied upon to witness popularity among individuals looking for IVF medicines. Expanding applications for preimplantation hereditary testing for analysis of infections like malignancy and other minor inabilities like deafness is relied upon to make high development open doors for preimplantation hereditary testing market partners.

Regional Outlook and Trend Analysis

Europe is expected to witness considerable growth over the forecast period. This biggest offer is credited to the expanded number of pregnancies that are relied upon to IVFs. Likewise, liberal controls in a few nations of this area for aneuploidy screening are foreseen to include potential roads in European PGT market.

Competitive Insights

The leading players in the market are Quest Diagnostics, Reproductive Health Science Ltd, Natera, Inc, CooperSurgical, Inc, Genea Limited, Good Start Genetics, Inc, LabCorp, California Pacific Medical Center, Thermo Fisher Scientific, Inc, Bioarray S.L and others.

The Preimplantation Genetic Testing Market is region-wise segmented as follows-

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • South Africa
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2023?
  • What will be the industry market growth from 2017 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Preimplantation Genetic Testing Market, By Type, Estimates and Forecast, 2014-2023 ($Million)

·         Chromosomal Abnormalities

·         X-linked Diseases

·         Freeze Embryo Testing

·         Aneuploidy Screening

·         HLA Typing

·         Other PGT Types

·         Preimplantation Genetic Testing Market, By Application, Estimates and Forecast, 2014-2023 ($Million)

·         Embryo HLA typing for stem cell therapy

·         IVF Prognosis

·         Late Onset Genetic Disorders

·         Inherited Genetic Disease

·         Other Applications

·         Preimplantation Genetic Testing Market, By Region, Estimates and Forecast, 2014-2023 ($Million)

·         North America

§  North America Preimplantation Genetic Testing Market, By Country

o    U.S. Preimplantation Genetic Testing Market

o    Canada Preimplantation Genetic Testing Market

o    Mexico Preimplantation Genetic Testing Market

·         Europe

§  Europe Preimplantation Genetic Testing Market, By Country

o    Germany Preimplantation Genetic Testing Market

o    UK Preimplantation Genetic Testing Market

o    France Preimplantation Genetic Testing Market

o    Russia Preimplantation Genetic Testing Market

o    Italy Preimplantation Genetic Testing Market

o    Rest of Europe Preimplantation Genetic Testing Market

·         Asia-Pacific

§  Asia-Pacific Preimplantation Genetic Testing Market, By Country

o    China Preimplantation Genetic Testing Market

o    Japan Preimplantation Genetic Testing Market

o    South Korea Preimplantation Genetic Testing Market

o    India Preimplantation Genetic Testing Market

o    Southeast Asia Preimplantation Genetic Testing Market

o    Rest of Asia-Pacific Preimplantation Genetic Testing Market

·         South America

§  South America Preimplantation Genetic Testing Market

o    Brazil Preimplantation Genetic Testing Market

o    Argentina Preimplantation Genetic Testing Market

o    Columbia Preimplantation Genetic Testing Market

o    South Africa Preimplantation Genetic Testing Market

o    Rest of South America Preimplantation Genetic Testing Market

·         Middle East and Africa

§  Middle East and Africa Preimplantation Genetic Testing Market

o    Saudi Arabia Preimplantation Genetic Testing Market

o    UAE Preimplantation Genetic Testing Market

o    Egypt Preimplantation Genetic Testing Market

o    Nigeria Preimplantation Genetic Testing Market

o    South Africa Preimplantation Genetic Testing Market

o    Rest of MEA Preimplantation Genetic Testing Market

Table of Contents

Chapter 1. Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

Chapter 2. Executive Summary

2.1.       Key Highlights

Chapter 3. Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.3.1.    Emerging Markets to Offer Lucrative Growth Opportunities

Chapter 4. Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2023)

4.1.2.  Canada Market States and Outlook (2017-2023)

4.1.3.  Mexico Market States and Outlook (2017-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2023)

4.2.2.  France Market States and Outlook (2017-2023)

4.2.3.  UK Market States and Outlook (2017-2023)

4.2.4.  Russia Market States and Outlook (2017-2023)

4.2.5.  Italy Market States and Outlook (2017-2023)

4.2.6.  Rest of Europe Market States and Outlook (2017-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2023)

4.3.2.  Japan Market States and Outlook (2017-2023)

4.3.3.  Korea Market States and Outlook (2017-2023)

4.3.4.  India Market States and Outlook (2017-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2017-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2023)

4.4.2.  Argentina Market States and Outlook (2017-2023)

4.4.3.  Columbia Market States and Outlook (2017-2023)

4.4.4.  Rest of South America Market States and Outlook (2017-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2023)

4.5.2.  UAE Market States and Outlook (2017-2023)

4.5.3.  Egypt Market States and Outlook (2017-2023)

4.5.4.  Nigeria Market States and Outlook (2017-2023)

4.5.5.  South Africa Market States and Outlook (2017-2023)

4.5.6.  Rest of MEA Market States and Outlook (2017-2023)

Chapter 5. Preimplantation Genetic Testing Market, By Type

5.1.       Introduction

5.2.       Global Preimplantation Genetic Testing Sales, Revenue and Market Share by Type (2017-2027)

5.2.1.  Global Preimplantation Genetic Testing Sales and Sales Share by Type (2017-2027)

5.2.2.  Global Preimplantation Genetic Testing Revenue and Revenue Share by Type (2017-2027)

5.3.       Chromosomal Abnormalities

5.3.1.  Global Chromosomal Abnormalities Sales and Growth Rate (2017-2027)

5.4.       X-linked Diseases

5.4.1.  Global X-linked Diseases Sales and Growth Rate (2017-2027)

5.5.       Freeze Embryo Testing

5.5.1.  Global Freeze Embryo Testing Sales and Growth Rate (2017-2027)

5.6.       Aneuploidy Screening

5.6.1.  Global Aneuploidy Screening Sales and Growth Rate (2017-2027)

5.7.       HLA Typing

5.7.1.  Global HLA Typing Sales and Growth Rate (2017-2027)

5.8.       Other PGT Types

5.8.1.  Global Other PGT Types Sales and Growth Rate (2017-2027)

Chapter 6. Preimplantation Genetic Testing Market, By Application

6.1.       Introduction

6.2.       Global Preimplantation Genetic Testing Sales, Revenue and Market Share by Application (2017-2027)

6.2.1.  Global Preimplantation Genetic Testing Sales and Sales Share by Application (2017-2027)

6.2.2.  Global Preimplantation Genetic Testing Revenue and Revenue Share by Application (2017-2027)

6.3.       Embryo HLA typing for stem cell therapy

6.3.1.  Global Embryo HLA typing for stem cell therapy Sales and Growth Rate (2017-2027)

6.4.       IVF Prognosis

6.4.1.  Global IVF Prognosis Sales and Growth Rate (2017-2027)

6.5.       Late Onset Genetic Disorders

6.5.1.  Global Late Onset Genetic Disorders Sales and Growth Rate (2017-2027)

6.6.       Inherited Genetic Disease

6.6.1.  Global Inherited Genetic Disease Sales and Growth Rate (2017-2027)

6.7.       Other Applications

6.7.1.  Global Other Applications Sales and Growth Rate (2017-2027)

Chapter 7. Preimplantation Genetic Testing Market, By Region

7.1.       Introduction

7.2.       Global Preimplantation Genetic Testing Sales, Revenue and Market Share by Regions

7.2.1.  Global Preimplantation Genetic Testing Sales by Regions (2017-2027)

7.2.2.  Global Preimplantation Genetic Testing Revenue by Regions (2017-2027)

7.3.       North America Preimplantation Genetic Testing by Countries

7.3.1.  North America Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.3.2.  North America Preimplantation Genetic Testing Revenue and Growth Rate (2017-2027)

7.3.3.  North America Preimplantation Genetic Testing Sales by Countries (2017-2027)

7.3.4.  North America Preimplantation Genetic Testing Revenue (Million USD) by Countries (2017-2027)

7.3.5.  U.S.

7.3.5.1.    United States Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.3.5.2.    United States Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.6.  Canada

7.3.6.1.    Canada Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.3.6.2.    Canada Preimplantation Genetic Testing Sales (Millions USD) and Growth Rate (2017-2027)

7.3.7.  Mexico

7.3.7.1.    Mexico Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.3.7.2.    Mexico Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.       Europe Preimplantation Genetic Testing by Countries

7.4.1.  Europe Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.4.2.  Europe Preimplantation Genetic Testing Revenue and Growth Rate (2017-2027)

7.4.3.  Europe Preimplantation Genetic Testing Sales by Countries (2017-2027)

7.4.4.  Europe Preimplantation Genetic Testing Revenue (Million USD) by Countries (2017-2027)

7.4.5.  Germany

7.4.5.1.    Germany Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.4.5.2.    Germany Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  UK

7.4.6.1.    UK Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.4.6.2.    UK Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  France

7.4.7.1.    France Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.4.7.2.    France Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Russia

7.4.8.1.    Russia Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.4.8.2.    Russia Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.9.  Italy

7.4.9.1.    Italy Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.4.9.2.    Italy Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.10.      Rest of Europe

7.4.10.1. Rest of Europe Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.4.10.2. Rest of Europe Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.       Asia-Pacific

7.5.1.  Asia-Pacific Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Preimplantation Genetic Testing Revenue and Growth Rate (2017-2027)

7.5.3.  Asia-Pacific Preimplantation Genetic Testing Sales by Countries (2017-2027)

7.5.4.  Asia-Pacific Preimplantation Genetic Testing Revenue (Million USD) by Countries (2017-2027)

7.5.5.  China

7.5.5.1.    China Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.5.5.2.    China Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  Japan

7.5.6.1.    Japan Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.5.6.2.    Japan Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.3.     

7.5.7.  Korea

7.5.7.1.    Korea Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.5.7.2.    Korea Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  India

7.5.8.1.    India Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.5.8.2.    India Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.9.  Southeast Asia

7.5.9.1.    Southeast Asia Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.5.9.2.    Southeast Asia Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.10.      Rest of Asia-Pacific

7.5.10.1. Rest of Asia-Pacific Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.5.10.2. Rest of Asia-Pacific Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.       South America

7.6.1.  South America Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.6.2.  South America Preimplantation Genetic Testing Revenue and Growth Rate (2017-2027)

7.6.3.  South America Preimplantation Genetic Testing Sales by Countries (2017-2027)

7.6.4.  South America Preimplantation Genetic Testing Revenue (Million USD) by Countries (2017-2027)

7.6.5.  Brazil

7.6.5.1.    Brazil Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.6.5.2.    Brazil Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Argentina

7.6.6.1.    Argentina Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.6.6.2.    Argentina Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.7.  Columbia

7.6.7.1.    Columbia Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.6.7.2.    Columbia Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.8.  Rest of South America

7.6.8.1.    Rest of South America Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.6.8.2.    Rest of South America Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.       Middle East and Africa

7.7.1.  Middle East and Africa Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Preimplantation Genetic Testing Revenue and Growth Rate (2017-2027)

7.7.3.  Middle East and Africa Preimplantation Genetic Testing Sales by Countries (2017-2027)

7.7.4.  Middle East and Africa Preimplantation Genetic Testing Revenue (Million USD) by Countries (2017-2027)

7.7.5.  Saudi Arabia

7.7.5.1.    Saudi Arabia Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.7.5.2.    Saudi Arabia Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  United Arab Emirates

7.7.6.1.    United Arab Emirates Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.7.6.2.    United Arab Emirates Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  Egypt

7.7.7.1.    Egypt Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.7.7.2.    Egypt Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Nigeria

7.7.8.1.    Nigeria Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.7.8.2.    Nigeria Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  South Africa

7.7.9.1.    South Africa Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.7.9.2.    South Africa Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.10.      Rest of Middle East and Africa

7.7.10.1. Rest of Middle East and Africa Preimplantation Genetic Testing Sales and Growth Rate (2017-2027)

7.7.10.2. Rest of Middle East and Africa Preimplantation Genetic Testing Revenue (Millions USD) and Growth Rate (2017-2027)

Chapter 8. Company Profiles

8.1.       F. Hoffmann-La Roche AG

8.1.1.  Business Overview

8.1.2.  Product Portfolio

8.1.3.  Strategic Developments

8.1.4.  Sales, Revenue and Market Share

8.2.       Genea Limited

8.2.1.  Business Overview

8.2.2.  Product Portfolio

8.2.3.  Strategic Developments

8.2.4.  Sales, Revenue and Market Share

8.3.       Quest Diagnostics

8.3.1.  Business Overview

8.3.2.  Product Portfolio

8.3.3.  Strategic Developments

8.3.4.  Sales, Revenue and Market Share

8.4.       Illumina, Inc.

8.4.1.  Business Overview

8.4.2.  Product Portfolio

8.4.3.  Strategic Developments

8.4.4.  Sales, Revenue and Market Share

8.5.       Natera, Inc.

8.5.1.  Business Overview

8.5.2.  Product Portfolio

8.5.3.  Strategic Developments

8.5.4.  Sales, Revenue and Market Share

8.6.       CooperSurgical, Inc.

8.6.1.  Business Overview

8.6.2.  Product Portfolio

8.6.3.  Strategic Developments

8.6.4.  Sales, Revenue and Market Share

8.7.       Laboratory Corporation of America Holdings (LabCorp)

8.7.1.  Business Overview

8.7.2.  Product Portfolio

8.7.3.  Strategic Developments

8.7.4.  Sales, Revenue and Market Share

8.8.       California Pacific Medical Center (CPMC)

8.8.1.  Business Overview

8.8.2.  Product Portfolio

8.8.3.  Strategic Developments

8.8.4.  Sales, Revenue and Market Share

8.9.       Thermo Fisher Scientific Inc.

8.9.1.  Business Overview

8.9.2.  Product Portfolio

8.9.3.  Strategic Developments

8.9.4.  Sales, Revenue and Market Share

8.10.    Igenomix

8.10.1.      Business Overview

8.10.2.      Product Portfolio

8.10.3.      Strategic Developments

8.10.4.      Sales, Revenue and Market Share

Chapter 9. Global Preimplantation Genetic Testing Market Competition, by Manufacturer

9.1.       Global Preimplantation Genetic Testing Sales and Market Share by Manufacturer (2017-2017)

9.2.       Global Preimplantation Genetic Testing Revenue and Market Share by Manufacturer (2017-2017)

9.3.       Global Preimplantation Genetic Testing Price by Manufacturer (2017-2017)

9.4.       Top 5 Preimplantation Genetic Testing Manufacturer Market Share

9.5.       Market Competition Trend

Chapter 10. Preimplantation Genetic Testing Market Forecast (2027-2023)

10.1.    Global Preimplantation Genetic Testing Sales, Revenue (Millions USD) and Growth Rate (2027-2023)

10.2.    Preimplantation Genetic Testing Market Forecast by Regions (2027-2023)

10.2.1.      North America Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.1.1. United States Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.1.2. Canada Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.1.3. Mexico Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.2.      Europe Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.2.1. Germany Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.2.2. United Kingdom Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.2.3. France Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.2.4. Russia Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.2.5. Italy Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.2.6. Rest of the Europe Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.3.      Asia-Pacific Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.3.1. China Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.3.2. Japan Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.3.3. Korea Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.3.4. India Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.3.5. Southeast Asia Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.3.6. Rest of Asia-Pacific Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.4.      South America Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.4.1. Brazil Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.4.2. Argentina Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.4.3. Columbia Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.4.4. Rest of South America Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.5.      Middle East and Africa Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.5.1. Saudi Arabia Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.5.2. UAE Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.5.3. Egypt Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.5.4. Nigeria Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.5.5. South Africa Preimplantation Genetic Testing Market Forecast (2027-2023)

10.2.5.6. Rest of MEA Preimplantation Genetic Testing Market Forecast (2027-2023)

10.3.    Preimplantation Genetic Testing Market Forecast by Type (2027-2023)

10.3.1.      Global Preimplantation Genetic Testing Sales Forecast by Type (2027-2023)

10.3.2.      Global Preimplantation Genetic Testing Sales Market Share Forecast by Type (2027-2023)

10.4.    Preimplantation Genetic Testing Market Forecast by Application (2027-2023)

10.4.1.      Global Preimplantation Genetic Testing Sales Forecast by Application (2027-2023)

10.4.2.      Global Preimplantation Genetic Testing Sales Market Share Forecast by Application (2027-2023)

List of Tables

(*You can glance through the list of Tables and Figures when you view the sample copy of Preimplantation Genetic Testing Market.)

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample